Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Placing

10 Aug 2009 07:00

RNS Number : 1293X
Imaginatik PLC
10 August 2009
 



10 August 2009

Imaginatik plc

("Imaginatik" or the "Company")

Placing to raise approximately £1.576 million

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaborative software and processes, announces that it has conditionally raised approximately £1.576 million through a placing of 26,266,666 new ordinary shares of 0.0625p each (the "Placing Shares") at a price of pence per share (the "Placing"). The Company intends that the net proceeds of the Placing will be used to provide the Company with the resources to pursue its growth plans and for general working capital purposes.

The Placing Shares have been conditionally placed by Arbuthnot Securities Limited ("Arbuthnot") with institutional and other investors. Application will be made to London Stock Exchange plc for the Placing Shares to be admitted to trading on AIM. Subject, inter alia, to admission of the Placing Shares to AIM becoming effective, dealings in the Placing Shares are expected to commence on AIM at 8.00 a.m. on 13 August 2009. The Placing Shares represent approximately 20 per cent. of the Company's existing issued share capital and will, when issued, represent approximately 16.5 per cent. of the Company's enlarged share capital. Following Admission, the Company will have 159,186,376 Ordinary Shares in issue.

Pursuant to the terms of the placing agreement, Arbuthnot, as agent for Imaginatik, has agreed to use its reasonable endeavours to place the Placing Shares with investors procured by it. The Placing is not underwritten. The Placing Price of 6 pence per Placing Share represents a discount of approximately 4 per cent. to the closing mid-market price of 6.25 pence per ordinary share on 7 August 2009, being the last dealing day prior to the date of this announcement.

The issue of the Placing Shares is conditional, amongst other things, on:

(i) admission to trading on AIM of the Placing Shares; and

(ii) the Placing Agreement not being terminated prior to Admission.

The Placing Agreement contains warranties given by the Company with respect to its business and certain matters connected with the Placing. In addition, the Company has given certain indemnities to Arbuthnot in connection with the Placing and Arbuthnot's performance of services in relation to the Placing.

Mark Turrell, CEO of Imaginatik, commented, "We are delighted to have secured this additional funding from new and existing investors. With the Placing oversubscribed, this is a very strong endorsement of the potential of Imaginatik, leaving us well positioned to pursue our growth strategy. Our pipeline continues to grow, which combined with our strong levels of recurring revenue, gives us confidence in our ability to capitalise on our market leading position." 

For further information, please contact:

Imaginatik plc
020 7917 2975
Mark Turrell, CEO
 
Shawn Taylor, CFO
 
 
 
Arbuthnot Securities Limited
020 7012 2000 
Tom Griffiths/Richard Johnson/
Niamh Corbett
 
 
 
ICIS
020 7651 8688
Caroline Evans-Jones/ Hilary Millar
 

About Imaginatik

Imaginatik is a leading provider of web-based enterprise collaboration software. Imaginatik's core software, Idea Central, is designed to help companies focus on idea generation towards strategic business objectives, and to share, develop and review those ideas across the organisation. Some of the world's largest organisations such as Merck, Dow, Chevron, General Electric and Cargill use Imaginatik's software, consulting and leading-edge research to enable their best-of-breed innovation, cost-reduction and process improvement activities.

Having been named as a World Economic Forum Technology Pioneer and a finalist for the IBM Lotus Awards in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as the Hult Business School in Boston, and the Cass School of Business, London, as well as leading practitioners of corporate innovation.

For further information please visit http://www.imaginatik.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUBVWRKNRWRAR
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.